Janssen’s Darzalex (daratumumab) received full approval by the European Commission (EC) for use in treating adult patients with multiple myeloma who have received at least one prior therapy. The EC approved Darzalex for use not only as a single therapy, but in combination with Revlimid (lenalidomide) and dexamethasone, or Velcade…
BioLineRx’s investigational drug BL-8040 has demonstrated positive interim results from a Phase 2 trial as a monotherapy for the mobilization and collection of donor blood stem cells for bone marrow transplants. In many blood diseases, bone marrow transplants have become a standard therapeutic procedure. This process requires that a donor’s healthy…
Patients undergoing hematopoietic (donor) stem cell transplants could benefit from treatment with the experimental drug letermovir, which prevents the common viral infection cytomegalovirus (CMV). These results may help improve the safety of stem cell transplants with fewer side effects. The findings were presented at the 2017 Bone Marrow Transplant Tandem Meetings…
Get regular updates to your inbox.